Docoh
Loading...

Mon. 15 Nov 2021, 8:13am ETBenzinga
In: News, Price Target, Analyst Ratings
JMP Securities analyst Gobind Singh maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Market Outperform and raises the price target from $60 to $70.